Answers are grounded in this paper and cite their sources.
Objective This study aimed to explore the regulatory effect and potential molecular mechanism of Lactobacillus rhamnosus on fat deposition in mice. Methods Twenty weaned male C57BL/6j mice were divided into control group (CK, n = 10) and Lactobacillus rhamnosus gavage group (LA, n = 10). The total experimental period was 44 days, including a 14-day pre-experiment adaptation period and a 30-day formal experimental period. At the end of the trial, body weight, abdominal fat content and fecal short-chain fatty acids (SCFAs) were determined. Combined with serum non-targeted metabolomics and lipidomics, the molecular regulation mechanism of Lactobacillus rhamnosus on fat deposition in mice was systematically investigated. Results There was no significant difference in body weight between LA group and CK group, while the abdominal fat content of LA group increased significantly ( P < 0.05). SCFA detection showed that the contents of acetic acid, propionic acid, butyric acid and isovaleric acid in LA group were extremely significantly higher than those in CK group ( P < 0.01), while isobutyric acid and valeric acid had no significant difference (*P*>0.05). Metabolomic analysis screened a total of 2186 differential metabolites (1669 up-regulated and 517 down-regulated), which were mainly enriched in lipid metabolism-related pathways such as glycerophospholipid metabolism, α-linolenic acid metabolism, linoleic acid metabolism and arachidonic acid metabolism. Lipidomic analysis identified 185 differential lipids (132 up-regulated and 53 down-regulated). Among them, PC, PE, PS and PI were significantly up-regulated, while Cer-s and Cer-NDS were significantly down-regulated. Differential lipids were mainly enriched in glycosylphosphatidylinositol anchor biosynthesis, inositol phosphate metabolism and phosphatidylinositol signaling system pathways. Conclusion In conclusion, Lactobacillus rhamnosus can promote abdominal fat deposition in mice without affecting body weight. It may regulate fat deposition by modulating intestinal SCFAs, glycerophospholipid metabolism and phosphatidylinositol signaling pathways. This study provides experimental evidence for elucidating the interaction network between probiotics and host lipid metabolism. Clinical trial registration Not applicable.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: